159 related articles for article (PubMed ID: 29858791)
21. Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
Gade TP; Hassen W; Santos E; Gunset G; Saudemont A; Gong MC; Brentjens R; Zhong XS; Stephan M; Stefanski J; Lyddane C; Osborne JR; Buchanan IM; Hall SJ; Heston WD; Rivière I; Larson SM; Koutcher JA; Sadelain M
Cancer Res; 2005 Oct; 65(19):9080-8. PubMed ID: 16204083
[TBL] [Abstract][Full Text] [Related]
22. Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma.
Shin J; Parker MFL; Zhu I; Alanizi A; Rodriguez CI; Liu R; Watchmaker PB; Kalita M; Blecha J; Luu J; Wright B; Lapi SE; Flavell RR; Okada H; Tlsty TD; Roybal KT; Wilson DM
J Nucl Med; 2023 Jan; 64(1):137-144. PubMed ID: 35981900
[TBL] [Abstract][Full Text] [Related]
23. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
24. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
Carpenter RO; Evbuomwan MO; Pittaluga S; Rose JJ; Raffeld M; Yang S; Gress RE; Hakim FT; Kochenderfer JN
Clin Cancer Res; 2013 Apr; 19(8):2048-60. PubMed ID: 23344265
[TBL] [Abstract][Full Text] [Related]
25. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts.
Perez C; Jukica A; Listopad JJ; Anders K; Kühl AA; Loddenkemper C; Blankenstein T; Charo J
Int J Cancer; 2015 Jul; 137(2):359-71. PubMed ID: 25530110
[TBL] [Abstract][Full Text] [Related]
26.
Mowday AM; Copp JN; Syddall SP; Dubois LJ; Wang J; Lieuwes NG; Biemans R; Ashoorzadeh A; Abbattista MR; Williams EM; Guise CP; Lambin P; Ackerley DF; Smaill JB; Theys J; Patterson AV
Theranostics; 2020; 10(23):10548-10562. PubMed ID: 32929365
[TBL] [Abstract][Full Text] [Related]
27. Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring.
Shao F; Long Y; Ji H; Jiang D; Lei P; Lan X
Theranostics; 2021; 11(14):6800-6817. PubMed ID: 34093854
[TBL] [Abstract][Full Text] [Related]
28. Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene.
Sellmyer MA; Richman SA; Lohith K; Hou C; Weng CC; Mach RH; O'Connor RS; Milone MC; Farwell MD
Mol Ther; 2020 Jan; 28(1):42-51. PubMed ID: 31668558
[TBL] [Abstract][Full Text] [Related]
29. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.
Milone MC; Fish JD; Carpenito C; Carroll RG; Binder GK; Teachey D; Samanta M; Lakhal M; Gloss B; Danet-Desnoyers G; Campana D; Riley JL; Grupp SA; June CH
Mol Ther; 2009 Aug; 17(8):1453-64. PubMed ID: 19384291
[TBL] [Abstract][Full Text] [Related]
30. Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.
McCracken MN; Gschweng EH; Nair-Gill E; McLaughlin J; Cooper AR; Riedinger M; Cheng D; Nosala C; Kohn DB; Witte ON
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1857-62. PubMed ID: 23319634
[TBL] [Abstract][Full Text] [Related]
31. Generation of Tumor Cells Expressing Firefly Luciferase (fLuc) to Evaluate the Effectiveness of CAR in a Murine Model.
de Souza Fernandes Pereira M; Fantacini DMC; Picanço-Castro V
Methods Mol Biol; 2020; 2086():237-250. PubMed ID: 31707681
[TBL] [Abstract][Full Text] [Related]
32. Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice.
Parente-Pereira AC; Burnet J; Ellison D; Foster J; Davies DM; van der Stegen S; Burbridge S; Chiapero-Stanke L; Wilkie S; Mather S; Maher J
J Clin Immunol; 2011 Aug; 31(4):710-8. PubMed ID: 21505816
[TBL] [Abstract][Full Text] [Related]
33. The PET-Tracer
Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
[TBL] [Abstract][Full Text] [Related]
34. Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.
Jensen MC; Riddell SR
Immunol Rev; 2014 Jan; 257(1):127-44. PubMed ID: 24329794
[TBL] [Abstract][Full Text] [Related]
35. Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Hegde M; Corder A; Chow KK; Mukherjee M; Ashoori A; Kew Y; Zhang YJ; Baskin DS; Merchant FA; Brawley VS; Byrd TT; Krebs S; Wu MF; Liu H; Heslop HE; Gottschalk S; Yvon E; Ahmed N
Mol Ther; 2013 Nov; 21(11):2087-101. PubMed ID: 23939024
[TBL] [Abstract][Full Text] [Related]
36. In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET.
Yusufi N; Mall S; Bianchi HO; Steiger K; Reder S; Klar R; Audehm S; Mustafa M; Nekolla S; Peschel C; Schwaiger M; Krackhardt AM; D'Alessandria C
Theranostics; 2017; 7(9):2402-2416. PubMed ID: 28744323
[TBL] [Abstract][Full Text] [Related]
37. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.
Chin FT; Namavari M; Levi J; Subbarayan M; Ray P; Chen X; Gambhir SS
Mol Imaging Biol; 2008; 10(2):82-91. PubMed ID: 18157580
[TBL] [Abstract][Full Text] [Related]
38. Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM.
Deng Z; Wu Y; Ma W; Zhang S; Zhang YQ
BMC Immunol; 2015 Jan; 16(1):1. PubMed ID: 25636521
[TBL] [Abstract][Full Text] [Related]
39.
Li X; Yin G; Ji W; Liu J; Zhang Y; Wang J; Zhu X; Zhu L; Dai D; Ma W; Xu W
Onco Targets Ther; 2020; 13():11659-11668. PubMed ID: 33223839
[TBL] [Abstract][Full Text] [Related]
40. Engineering T cells for adoptive therapy: outsmarting the tumor.
Kunert A; Debets R
Curr Opin Immunol; 2018 Apr; 51():133-139. PubMed ID: 29579622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
